Veritas In Silico (TSE:130A) Total Assets: 円1,884.91 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:130A Veritas In Silico Inc TSE:130A
11 GF Score
Price 円418.00
! 4 Warning Signs
View Full Analysis

What is Veritas In Silico Total Assets?

Veritas In Silico TSE:130A -3.91% 11 Total Assets is 円1,884.91 Mil as of Dec. 2025. GuruFocus rates TSE:130A with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Veritas In Silico's Total Assets for the quarter that ended in Dec. 2025 was 円1,884.91 Mil.

During the past 12 months, Veritas In Silico's average Total Assets Growth Rate was -21.00% per year. During the past 3 years, the average Total Assets Growth Rate was -19.40% per year.

During the past 5 years, Veritas In Silico's highest 3-Year average Total Assets Growth Rate was 4.60%. The lowest was -19.40%. And the median was -7.40%.

Total Assets is connected with ROA %. Veritas In Silico's annualized ROA % for the quarter that ended in Dec. 2025 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Veritas In Silico's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Veritas In Silico  (TSE:130A) Total Assets Explanation

Total Assets is connected with ROA %.

Veritas In Silico's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (1984.823+1884.912)/ 2 )
=0/1934.8675
=0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Veritas In Silico's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (1984.823+1884.912)/ 2 )
=0/1934.8675
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Veritas In Silico Total Assets Related Terms

Veritas In Silico Total Assets Historical Data

* Premium members only.

The historical data trend for Veritas In Silico's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico Total Assets Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
1,754.79 1,598.58 1,655.53 2,248.96 1,884.91

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,184.39 2,070.94 1,984.82 1,884.91 1,785.38
TSE:130A
11GF Score
Veritas In Silico Inc TSE:130A
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veritas In Silico Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Veritas In Silico's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=1783.876+101.036
=1,884.91

Veritas In Silico's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=1783.876+101.036
=1,884.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of 円1,884.91 Mil mean?
Veritas In Silico (TSE:130A) has a Total Assets of 円1,884.91 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Veritas In Silico and its competitors.
Is Veritas In Silico's Total Assets too high?
Veritas In Silico's current Total Assets is 円1,884.91 Mil. Overall, Veritas In Silico has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Veritas In Silico's Total Assets compare to VRTX and REGN?
Veritas In Silico's Total Assets of 円1,884.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Veritas In Silico and its competitors. Veritas In Silico's current Total Assets is 円1,884.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veritas In Silico stock overvalued right now?
Veritas In Silico (TSE:130A) has a current Total Assets of 円1,884.91 Mil. The current Total Assets is 円1,884.91 Mil. Veritas In Silico's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Veritas In Silico (TSE:130A), the current Total Assets is 円1,884.91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veritas In Silico Business Description

Address 1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
11GF Score

Get the complete analysis for TSE:130A

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円418.00
Price